Stock Track | Hims & Hers Health Soars 5.05% on CVS-Novo Nordisk Partnership News

Stock Track

May 01, 2025

Hims & Hers Health Inc. (HIMS) saw its stock price surge by 5.05% in pre-market trading on Thursday, as investors reacted to news indirectly related to the company's involvement in the booming weight-loss drug market.

The stock's movement appears to be linked to CVS Health's announcement of a new partnership with Novo Nordisk, the maker of the popular weight-loss drug Wegovy. In its earnings report, CVS revealed that it would be the first retail pharmacy to partner with NovoCare, Novo Nordisk's online direct-to-consumer platform. Notably, the report mentioned that Hims & Hers, along with another telehealth platform Ro, are also partners with Novo Nordisk for distributing Wegovy.

This development highlights the growing importance of the weight-loss drug market and the potential benefits for companies involved in its distribution. As a partner in Novo Nordisk's distribution network, Hims & Hers is well-positioned to capitalize on the increasing demand for Wegovy and similar GLP-1 drugs. The market's positive reaction to this news suggests that investors see significant growth potential for HIMS in this rapidly expanding sector of the healthcare industry.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1151621058"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1151621058\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1151621058?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-01 22:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151621058","market":"sg","top_or_hot":-1,"title":"Stock Track | Hims & Hers Health Soars 5.05% on CVS-Novo Nordisk Partnership News","media":"Stock Track","content":"<p>Hims & Hers Health Inc. (HIMS) saw its stock price surge by 5.05% in pre-market trading on Thursday, as investors reacted to news indirectly related to the company's involvement in the booming weight-loss drug market.</p>\n\n<p>The stock's movement appears to be linked to CVS Health's announcement of a new partnership with Novo Nordisk, the maker of the popular weight-loss drug Wegovy. In its earnings report, CVS revealed that it would be the first retail pharmacy to partner with NovoCare, Novo Nordisk's online direct-to-consumer platform. Notably, the report mentioned that Hims & Hers, along with another telehealth platform Ro, are also partners with Novo Nordisk for distributing Wegovy.</p>\n\n<p>This development highlights the growing importance of the weight-loss drug market and the potential benefits for companies involved in its distribution. As a partner in Novo Nordisk's distribution network, Hims & Hers is well-positioned to capitalize on the increasing demand for Wegovy and similar GLP-1 drugs. The market's positive reaction to this news suggests that investors see significant growth potential for HIMS in this rapidly expanding sector of the healthcare industry.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Hims & Hers Health Soars 5.05% on CVS-Novo Nordisk Partnership News</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Hims & Hers Health Soars 5.05% on CVS-Novo Nordisk Partnership News\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-01 22:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hims & Hers Health Inc. (HIMS) saw its stock price surge by 5.05% in pre-market trading on Thursday, as investors reacted to news indirectly related to the company's involvement in the booming weight-loss drug market.</p>\n\n<p>The stock's movement appears to be linked to CVS Health's announcement of a new partnership with Novo Nordisk, the maker of the popular weight-loss drug Wegovy. In its earnings report, CVS revealed that it would be the first retail pharmacy to partner with NovoCare, Novo Nordisk's online direct-to-consumer platform. Notably, the report mentioned that Hims & Hers, along with another telehealth platform Ro, are also partners with Novo Nordisk for distributing Wegovy.</p>\n\n<p>This development highlights the growing importance of the weight-loss drug market and the potential benefits for companies involved in its distribution. As a partner in Novo Nordisk's distribution network, Hims & Hers is well-positioned to capitalize on the increasing demand for Wegovy and similar GLP-1 drugs. The market's positive reaction to this news suggests that investors see significant growth potential for HIMS in this rapidly expanding sector of the healthcare industry.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMS","symbol_name":"Hims & Hers Health Inc.","start_time":0,"source_url":"","article_id":"1151621058","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151621058","pubTimestamp":1746111404,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Hims & Hers Health Inc.  saw its stock price surge by 5.05% in pre-market trading on Thursday, as investors reacted to news indirectly related to the company's involvement in the booming weight-loss drug market.The stock's movement appears to be linked to CVS Health's announcement of a new partnership with Novo Nordisk, the maker of the popular weight-loss drug Wegovy. In its earnings report, CVS revealed that it would be the first retail pharmacy to partner with NovoCare, Novo Nordisk's online ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"translate_title":"股票跟踪Hims&Hers Health因CVS飙升5.05%-诺和诺德合作新闻","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":1},"content_text":"Hims & Hers Health Inc. (HIMS) saw its stock price surge by 5.05% in pre-market trading on Thursday, as investors reacted to news indirectly related to the company's involvement in the booming weight-loss drug market.\nThe stock's movement appears to be linked to CVS Health's announcement of a new partnership with Novo Nordisk, the maker of the popular weight-loss drug Wegovy. In its earnings report, CVS revealed that it would be the first retail pharmacy to partner with NovoCare, Novo Nordisk's online direct-to-consumer platform. Notably, the report mentioned that Hims & Hers, along with another telehealth platform Ro, are also partners with Novo Nordisk for distributing Wegovy.\nThis development highlights the growing importance of the weight-loss drug market and the potential benefits for companies involved in its distribution. As a partner in Novo Nordisk's distribution network, Hims & Hers is well-positioned to capitalize on the increasing demand for Wegovy and similar GLP-1 drugs. The market's positive reaction to this news suggests that investors see significant growth potential for HIMS in this rapidly expanding sector of the healthcare industry.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}